Pharmaceutical

FDA genAI reviews hinge on clarity of dossiers

The FDA's new genAI-assisted scientific review technology, named Elsa, was officially adopted by the agency on 2 June.

Jun 25, 2025 - 06:00
FDA genAI reviews hinge on clarity of dossiers
The FDA's new genAI-assisted scientific review technology, named Elsa, was officially adopted by the agency on 2 June.
Read the original article

Tags:

Previous Article

Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug

Next Article

FDA approves AstraZeneca and Daiichi Sankyo’s Datroway for NSCLC

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: U.S. Senate eyes more policies for regulating PBMs; Novo claims most U.S. Wegovy patients pay less than $25 a month

STAT+: Pharmalittle: U.S. Senate eyes more policies for...

Nov 3, 2023

Roche relaunches refillable wet AMD implant two years after recall

Roche relaunches refillable wet AMD implant two years a...

Jul 10, 2024

Suicide hotlines promise anonymity. Dozens of their websites send sensitive data to Facebook

Suicide hotlines promise anonymity. Dozens of their web...

Jun 14, 2023